Generic Name: Estriol (Vaginal)
Therapeutic Class: Topical Estrogen / Hormone Replacement Therapy (HRT)
Indications
Estriol vaginal preparations are primarily used to treat symptoms caused by estrogen deficiency in the urogenital tract:
- Atrophic Vaginitis: Treatment of vaginal dryness, itching, and painful intercourse (dyspareunia) in postmenopausal women.
- Urinary Symptoms: Management of urinary urgency, frequency, and painful urination associated with urogenital atrophy.
- Pre- and Post-operative Therapy: Used in postmenopausal women undergoing vaginal surgery to improve wound healing.
- Diagnostic Aid: Helps in cases of doubtful atrophic cervical smears for more accurate cytological assessment.
- Recurrent Infections: Prevention of recurrent vaginal or lower urinary tract infections.
Presentation
The medication is available in local application forms to minimize systemic exposure:
- Vaginal Cream: Typically contains 1 mg of Estriol per 1 gram of cream, supplied with a calibrated applicator.
- Vaginal Pessary/Suppository: Usually contains 0.5 mg of Estriol for easy insertion.
Description & Pharmacokinetics
Estriol is a natural female sex hormone. Unlike other estrogens, Estriol is short-acting because it has a short retention time in the nuclei of endometrial cells. When applied locally in the vagina, it restores the normal vaginal flora and the physiological pH, increases the resistance of the vaginal epithelial cells to infection and inflammation, and reduces physical discomfort.
Pharmacokinetically, local administration of Estriol ensures that the hormone is delivered directly to the target tissues. While some systemic absorption does occur, it is generally much lower than oral estrogen therapy, leading to a safer profile regarding the stimulation of the endometrium (uterine lining). It is rapidly eliminated from the body through the urine.
Pharmacokinetically, local administration of Estriol ensures that the hormone is delivered directly to the target tissues. While some systemic absorption does occur, it is generally much lower than oral estrogen therapy, leading to a safer profile regarding the stimulation of the endometrium (uterine lining). It is rapidly eliminated from the body through the urine.
Extra Important Information: Clinical Use & Safety
For optimal results and safety, the following clinical insights are provided:
- Application Timing: It is best applied at bedtime to ensure the medication stays in place for a sufficient duration.
- Dose Titration: Treatment usually starts with a daily application for the first 2 to 3 weeks, followed by a maintenance dose of twice-weekly applications.
- Endometrial Safety: Because Estriol is short-acting and used locally at low doses, it typically does not require a progestogen to protect the uterus in women with an intact uterus, though long-term use should be monitored.
- Latex Interaction: Some vaginal creams may weaken latex products like condoms or diaphragms. Patients should be advised on alternative contraceptive methods if applicable.
Side Effects
Common local side effects may include:
- Local irritation, itching, or a burning sensation during the first few days of treatment.
- Increased vaginal discharge.
- Breast tenderness or discomfort (rare at low doses).
- Mild spotting or breakthrough bleeding (should be reported to a doctor).
Pregnancy & Lactation
- Pregnancy: Strictly contraindicated. There is no indication for the use of Estriol during pregnancy. If pregnancy occurs during treatment, Estriol should be withdrawn immediately.
- Lactation: Not recommended. Estriol is excreted in breast milk and may decrease the quality and quantity of milk production.
Precautions & Interactions
- Undiagnosed Bleeding: Must not be used in patients with undiagnosed vaginal bleeding.
- History of Cancer: Contraindicated in women with known or suspected estrogen-dependent tumors (e.g., breast or endometrial cancer).
- Thrombosis: Caution in patients with a history of deep vein thrombosis (DVT) or pulmonary embolism.
- Drug Interactions: While systemic interaction is low, drugs like Rifampicin or Phenobarbital might increase the metabolism of estrogens.
Storage
Store at room temperature below 30°C. Protect from light and freezing. Keep the tube or foil tightly closed and out of reach of children.
.png)
